choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Prolia (Denosumab)

Prolia (Denosumab) Newsletter
  • Amgen profit rises, weight-loss data expected in 4th quarter 06 Aug 2025 04:27 GMT

    … weight-loss drug MariTide. The California-based biotech company’s … medication Repatha rose 31% to $696 million. Sales of bone drug Prolia … at MariTide as a treatment for type 2 diabetes. … in the future. The pharmaceutical industry is facing intense pressure …

  • Amgen quarterly results beat Wall Street estimates 06 Aug 2025 03:29 GMT

    … expenses. The California-based biotech company’s second-quarter … medication Repatha rose 31% to $696 million. Sales of bone drug Prolia … at MariTide as a treatment for type 2 diabetes. … in the future. The pharmaceutical industry is facing intense pressure …

  • Uncovering Potential: Amgen's Earnings Preview 04 Aug 2025 14:47 GMT

    … Gilead Sciences, Vertex Pharmaceuticals and Regeneron Pharmaceuticals, three prominent industry … Amgen Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs … 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) …

  • Breaking Down Every FDA Approval Across Oncology During July 2025 02 Aug 2025 17:40 GMT

    … during the trial. Cytokine release … denosumab-bmwo) and Osenvelt (denosumab-bmwo), biosimilars to Prolia … settlement with Amgen regarding our denosumab biosimilars. … FDA Approval for the Treatment of Unresectable Hepatocellular Carcinoma,” by Sirtex Medical …

  • Amgen and Accord Settle Prolia® / Xgeva® BPCIA Litigation over INTP23 30 Jul 2025 17:50 GMT

    … of Amgen’s patents by Accord’s proposed Prolia® / Xgeva® (denosumab) biosimilar … INTP23 (previously reported BPCIA Lawsuit Against Accord’s Proposed Prolia … ® / Xgeva® Biosimilar Filed by Amgen). ... By: …

  • Biocon Regulatory Approval Updates in the U.S. and Europe: Insulin Aspart and Denosumab 30 Jul 2025 17:48 GMT

    … glargine-yfgn), the first FDA-approved interchangeable biosimilar insulin … (“EC”) granted two denosumab biosimilars, VEVZUO and EVFRAXY … and EVFRAXY reference Amgen’s XGEVA and PROLIA, respectively. The … is authorized for the treatment of osteoporosis and bone …

  • Human medicines European public assessment report (EPAR): Bildyos, denosumab, Status: Opinion 25 Jul 2025 10:00 GMT

    … substance of Bildyos is denosumab, a medicine for the treatment of bone diseases … biosimilar medicinal product. It is highly similar to the reference product Prolia (denosumab … and efficacy to Prolia. The full indication is: Treatment of osteoporosis in …

  • Dear Doctor: I read that taking Fosamax can cause high blood pressure. My doctor doesn’t agree 25 Jul 2025 13:27 GMT

    … trial showing that Fosamax can cause high blood pressure, but my doctor … I tend not to use denosumab (Prolia) or bisphosphonates, both of … I currently take several medications and supplements daily that are … third. The material that drug capsules are made from …

  • Low DEXA score in man calls for a bone-growth medicine 25 Jul 2025 08:56 GMT

    … times a week. My doctor put me on Prolia, and I had … trial showing that Fosamax can cause high blood pressure, but my doctor … . Do I try the other drugs one at a time, or …

  • Dr. Roach: Low DEXA score in man calls for a bone-growth medicine 25 Jul 2025 04:44 GMT

    … trial showing that Fosamax can cause high blood pressure, but my doctor … I tend not to use denosumab (Prolia) or bisphosphonates, both of … I currently take several medications and supplements daily that are … third. The material that drug capsules are made from …

Satisfied with the content?

Continue to create your account.